Hospital or health organisation · founded 1881
Hackensack University Medical Center
Hackensack, United States · hackensackumc.org
- Citations, last 5 years
- 18.4k
- Works, last 5 years
- 2 510
- h-index
- 322
- Scientists listed
- 0
- Grants since 2016
- 224
Grants received
2023–2028 · research · R01
Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease
Courtney C Aldrich · Hackensack University Medical Center · funded by National Institutes of Health
2023–2028 · research · R01
Identifying and characterizing functional noncoding mutations in multiple myeloma
Benjamin Tycko · Hackensack University Medical Center · funded by National Institutes of Health
2023–2030 · cooperative agreement · UH3
Enriching ECHO Cohorts with High-risk Pregnancies and Children with Health Challenges (Enriching ECHO)
Judy Lynn Aschner · Hackensack University Medical Center · funded by National Institutes of Health
2022–2027 · research · R37
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
Johannes Zakrzewski · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · research · R21
Elucidating mediators of genetic instability in Candida glabrata
Erika Shor · Hackensack University Medical Center · funded by National Institutes of Health
2022–2024 · research · R01
Study of Interleukin 33 as a new immunotherapy of lung cancer
Song Li · Hackensack University Medical Center · funded by National Institutes of Health
2022–2024 · research · R21
Identifying drug-resistant Candida species using SuperSelective primer PCR
Neeraj Chauhan · Hackensack University Medical Center · funded by National Institutes of Health
2022–2026 · research · R01
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
Binfeng Lu · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · research · R00
Elucidating the Role of SMAD4 in Colorectal Cancer
Kevin Tong · Hackensack University Medical Center · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations
Lisa Carter-Bawa · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · research · R01
Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening
Lisa Carter-Bawa · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · research · R21
Identifying drug-resistant Candida species using SuperSelective primer PCR
Neeraj Chauhan · Hackensack University Medical Center · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations
Lisa Carter-Bawa · Hackensack University Medical Center · funded by National Institutes of Health
2022–2026 · research · R00
Elucidating the Role of SMAD4 in Colorectal Cancer
Kevin Tong · Hackensack University Medical Center · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations
Lisa Carter-Bawa · Hackensack University Medical Center · funded by National Institutes of Health
2022–2027 · research · R37
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
Johannes Zakrzewski · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Metropolitan AntiViral Drug Accelerator
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2022–2024 · grant · KCRP
Pinpointing Functional Noncoding Mutations in ccRCC
Benjamin Tycko · Hackensack University Medical Center · funded by Congressionally Directed Medical Research Programs
2022–2027 · research · R37
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
Johannes Zakrzewski · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · research · R00
Elucidating the Role of SMAD4 in Colorectal Cancer
Kevin Tong · Hackensack University Medical Center · funded by National Institutes of Health
2022–2026 · research · R01
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
Binfeng Lu · Hackensack University Medical Center · funded by National Institutes of Health
2022–2026 · research · R01
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
Binfeng Lu · Hackensack University Medical Center · funded by National Institutes of Health
2022–2024 · research · R21
Elucidating mediators of genetic instability in Candida glabrata
Erika Shor · Hackensack University Medical Center · funded by National Institutes of Health
2022–2027 · research · R37
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
Johannes Zakrzewski · Hackensack University Medical Center · funded by National Institutes of Health
2022–2027 · research · R01
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
Binfeng Lu · Hackensack University Medical Center · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations
Lisa Carter-Bawa · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Multiplex Small Molecule Discovery to Identify Broad-Acting Viral Protease Inhibitors
David D Ho · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Administrative Core
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Animal Model Core
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Accelerated development of advanced leads against SARS-CoV-2 and other pandemic viruses
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
High Throughput Screening Core
Joseph Fraser Glickman · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Discovery of new antiviral methylase, protease, and helicase inhibitors of corona-, flavi-, and alphaviruses
Thomas Tuschl · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Discovery and Optimization of Inhibitors of SARS-CoV-2 Polymerase and Exonuclease
Jingyue Ju · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Development of ALG-097431 as a broad-spectrum 3CL pro inhibitor
Julian A Symons · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Virology Core
Charles M Rice · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Structural Biology and Computational Modeling Core
Lawrence S Shapiro · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Pharmacology Core
Veronique Dartois · Hackensack University Medical Center · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Medicinal Chemistry Core
James M Balkovec · Hackensack University Medical Center · funded by National Institutes of Health
2021–2026 · research · R01
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
Martin Alfons Gengenbacher · Hackensack University Medical Center · funded by National Institutes of Health
2021–2026 · research · R01
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
Martin Alfons Gengenbacher · Hackensack University Medical Center · funded by National Institutes of Health